Literature DB >> 1743185

Seizure frequency, patient-perceived seizure severity and the psychosocial consequences of intractable epilepsy.

D F Smith1, G A Baker, M Dewey, A Jacoby, D W Chadwick.   

Abstract

It is generally recognised that the assessment of treatment effects in epilepsy using seizure frequency as the only outcome measure may lack sensitivity. A patient-based seizure severity scale has been developed and initial results confirm its reliability and validity. As part of the further development of this scale it is important to explore the relationship between seizure severity, seizure frequency and the psychosocial consequences of intractable epilepsy. One hundred patients with medically refractory partial seizures completed a quality of life questionnaire including measures of physical (seizure severity and frequency), social and psychological well-being (anxiety, depression, self-esteem, locus of control and happiness). Multivariate analysis demonstrated that individual psychological variables were best predicted by other psychological variables. However, when these were removed from analysis, seizure severity was the most significant predictor of self-esteem (P = 0.005), locus of control P = 0.039) and anxiety (P = 0.048). Seizure frequency did not contribute significantly to the variance of any of the psychological factors. These results highlight the importance of considering seizure severity when assessing treatment effects in epilepsy and provide further evidence for the construct validity of a novel patient-based seizure severity scale.

Entities:  

Mesh:

Year:  1991        PMID: 1743185     DOI: 10.1016/0920-1211(91)90057-m

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  17 in total

1.  Quality of life after epilepsy surgery.

Authors:  M W Kellett; D F Smith; G A Baker; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-07       Impact factor: 10.154

2.  The impact of a depression self-management intervention on seizure activity.

Authors:  Nancy J Thompson; Robin E McGee; Amanda Garcia-Williams; Linda M Selwa; Shelley C Stoll; Erica K Johnson; Robert T Fraser
Journal:  Epilepsy Behav       Date:  2019-10-22       Impact factor: 2.937

Review 3.  Epidemiology and drug treatment of epilepsy in elderly people.

Authors:  E Faught
Journal:  Drugs Aging       Date:  1999-10       Impact factor: 3.923

4.  The contribution of the measurement of seizure severity to quality of life research.

Authors:  D Smith; G A Baker; A Jacoby; D W Chadwick
Journal:  Qual Life Res       Date:  1995-04       Impact factor: 4.147

Review 5.  Quality of life as an outcome measure for epilepsy clinical trials.

Authors:  J A Cramer
Journal:  Pharm World Sci       Date:  1997-10

6.  Safety, efficacy, and life satisfaction following epilepsy surgery in patients aged 60 years and older.

Authors:  Sandra Dewar; Dawn Eliashiv; Patricia D Walshaw; Jerome Engel; Itzhak Fried; Brian D Moseley
Journal:  J Neurosurg       Date:  2015-09-18       Impact factor: 5.115

7.  Reliability and Validity of the Korean Version of QOLIE-10 in Epilepsy.

Authors:  Sang-Ahm Lee; Sung-Cheol Yun; Byung-In Lee
Journal:  J Clin Neurol       Date:  2006-12-20       Impact factor: 3.077

8.  Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.

Authors:  David Victorson; Jose E Cavazos; Gregory L Holmes; Anthony T Reder; Valerie Wojna; Cindy Nowinski; Deborah Miller; Sarah Buono; Allison Mueller; Claudia Moy; David Cella
Journal:  Epilepsy Behav       Date:  2013-12-20       Impact factor: 2.937

Review 9.  Stress, seizures, and hypothalamic-pituitary-adrenal axis targets for the treatment of epilepsy.

Authors:  Jamie Maguire; Jay A Salpekar
Journal:  Epilepsy Behav       Date:  2012-11-29       Impact factor: 2.937

10.  Adaptation and evaluation of the Liverpool Seizure Severity Scale and Liverpool Quality of Life battery for American epilepsy patients.

Authors:  S Rapp; S Shumaker; T Smith; P Gibson; R Berzon; R Hoffman
Journal:  Qual Life Res       Date:  1998-05       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.